Epic Bio Reports New Data on Hypercompact Cas Proteins Optimized for Broad Therapeutic Applicability

– Data being presented at ESGCT reflect improvements upon CasMINI, previously the smallest Cas protein known to work in human cells – – Company’s additional poster presentations report on progress of epigenetic editing platform and lead candidate EPI-321 – SOUTH SAN FRANCISCO, Calif. — October 26, 2023 — Epic Bio, a biotechnology company developing therapies to … Read more

Epic Bio Named a “Fierce 15” Company by Fierce Biotech  

SOUTH SAN FRANCISCO, Calif. — August 28, 2023 — Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, has been named to Fierce Biotech’s 2023 “Fierce 15” list, designating it as one of the most outstanding early-stage biotechnology companies in the industry. “We are very proud to be recognized … Read more